08:30 - 09:00 h - Swiss Society of Pharmacology and Toxicology

Document technical information

Format docx
Size 38.1 kB
First found May 22, 2018

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Persons

Anaïs Nin
Anaïs Nin

wikipedia, lookup

Organizations

Places

Transcript

Swiss Society of Pharmacology and Toxicology
SSPT Spring Meeting 2014
Auditorium Langhans, Inselspital Bern
Thursday April 03, 2014
Organizers:
Stephan von Gunten (University Bern), Hugo Kupferschmidt (STIC),
Gabriele Weitz-Schmidt (AlloCyte Pharmaceuticals AG)
Deadlines:
Abstract Deadline:
New: February 28, 2014
Registration Deadline: New: March 25, 2014
Programme
Registration and Poster Set-Up
(08:30 - 09:00 h)
Pharmacology and Toxicology in Times of Change
(09:00 - 12:50 h)
Chairs:
09:00 - 09:10
Hugo Kupferschmidt, Swiss Toxicological Information Center, Zürich
Thomas Weiser, Hoffmann-La Roche AG, Basel
Welcome address and introduction of SSPT president
Hugo Kupferschmidt, Swiss Toxicological Information Center, Zürich
09:10 - 09:35
“Experimental pharmacology – More than cell biology ?”
Hanns Ulrich Zeilhofer, Institute of Pharmacology and Toxicology,
University of Zürich
09:35 - 10:00
Toxicology: “From haruspicy to adverse outcome pathways - a
paradigm shift in safety testing”
Martin Wilks, Swiss Centre for Applied Human Toxicology, University of
Basel
10:00 - 10:25
“The future of academic clinical pharmacology – Bright with some
clouds”
Stephan Krähenbühl, Clinical Pharmacology and Toxicology,
University Basel
1
Swiss Society of Pharmacology and Toxicology
Coffee Break and Poster Viewing
(10:25 - 11:00 h)
11:00 - 11:25
Pharmaceutical medicine: “In times of change: Take up a clear position
and provide orientation”
Peter Kleist, Medical Department, GlaxoSmithKline AG, Münchenbuchsee
11:25 - 11:50
“Open PHACTS - Building an open pharmacological space”
Gerhard F. Ecker, Department of Medicinal Chemistry, University Vienna
11:50 - 12:15
“SNSF initiatives: Funding schemes, opportunities, perspectives”
Aysim Yilmaz, Division Biology and Medicine, Swiss National Science
Foundation (SNSF), Bern
12:15 - 12:40
"Why is it important to increase visibility of life sciences communities?"
Thierry Soldati, Department of Biochemistry, University Geneva
Poster Session: Pharmacology and Toxicology Research in Switzerland
& Buffet Lunch (12:40 - 14:00 h)
Working as a Pharmacologist or Toxicologist: Insights from Inside
(14:00 - 15:20 h)
Chair:
14:00 -14:20
Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel
Leonardo Scapozza, School of Pharmaceutical Sciences, Univ. Geneva
“Target-to-therapy - An interdisciplinary approach to drug development”
Tobias Junt, Research Investigator, Novartis Institutes of Biomedical
Research, Basel
14:20 -14:40
“Insights from inside: Challenges and opportunities of becoming an
entrepreneur in drug development”
Vladimir Cmiljanovic, CEO, PIQUR Therapeutics AG, Basel
14:40 -15:00
“Working as toxicologist in times of change”
Elisabeth Rosner, Senior Project Toxicologist, Novartis Pharma AG, Basel
15:00 -15:20
“From Lab to Market – Why should universities file patents?”
Martin Binggeli, Technology Transfer Manager, Technology Transfer
University Basel, Bern, Zürich (Unitectra)
2
Swiss Society of Pharmacology and Toxicology
Interactive Coffee Break
(15:20 - 16:00 h)
Young Investigator Research
(16:00 - 17:00 h)
Chair:
16:00 - 16:15
Stephan von Gunten, Institute of Pharmacology, University Bern
“Dopaminergic Role in Regulating Neurophysiological Markers of
Sleep Homeostasis in Humans”
Sebastian C. Holst, Institute of Pharmacology and Toxicology, University
Zürich
16:15 - 16:30
“Siglec-7/-9 ligand-receptor interactions in NK cell-mediated tumor
immunosurveillance”
Kayluz Frias Boligan, Institute of Pharmacology, University Bern
16:30 - 16:45
“3D engineered nervous tissues derived from human embryonic stem
cells and IPs cells as in vitro models for neurotoxicity studies”
Adrien Roux, University of Applied Sciences Western Switzerland, Geneva
16:45 - 17:00
Lecture of the Bürgi Prize recipient
Bürgi Prize for best PhD thesis
Novartis Prize for best poster and best oral talk
(17:00 - 17:15 h)
Closing Remarks and End of Meeting
(17:15 - 17:30 h)
3

Similar documents

×

Report this document